-
iRGD peptide
- names:
iRGD peptide
- CAS号:
1392278-76-0
MDL Number: - MF(分子式): C35H57N13O14S2 MW(分子量): 948.04
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002808-5mg | 5mg | 98.62% | ¥ 5940.00 | ¥ 5940.00 | 2-3天 | ¥ 0.00 | ||
| YZM002808-1mg | 1mg | 98.62% | ¥ 1430.00 | ¥ 1430.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1392278-76-0 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C35H57N13O14S2 |
| 分子量 Molecular Weight | 948.04 |
| 溶解度Solubility | 生物体外In Vitro:H2O≥ 50 mg/mL(52.74 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | Protect from light 粉末Powder: -80°C 2 years年 -20°C 1 year / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
iRGD peptide(CAS:1392278-76-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | iRGD peptide 是一种有效的由 9 个氨基酸组成的环肽,先与av integrins结合,随后酶解产生 CRGDK/R 与 神经纤毛蛋白-1 (neuropilin-1) 相互作用,从而促进药物的组织渗透,具有靶向肿瘤、肿瘤渗透的作用 |
| Introduction | iRGD peptide is a 9mino acid cyclic peptide, triggers tissue penetration of drugs by first binding toav integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin, and has tumorargeting and tumorenetrating properties. |
| Application1 | |
| Application2 | |
| Application3 |
iRGD peptide 是一种有效的由 9 个氨基酸组成的环肽,先与av integrins结合,随后酶解产生 CRGDK/R 与 神经纤毛蛋白-1 (neuropilin-1) 相互作用,从而促进药物的组织渗透,具有靶向肿瘤、肿瘤渗透的作用。iRGD peptide is a 9-amino acid cyclic peptide, triggers tissue penetration of drugs by first binding toav integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties.
【1】.Puig-Saus C, et al. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther. 2014 Aug;21(8):767-74.
【2】.Zhang L, et al. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother. 2017 Sep;93:1136-1143.
【2】.Zhang L, et al. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother. 2017 Sep;93:1136-1143.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


